Results Kairos Pharma Ltd.
-
Investor Presentation (10/10/2024 08:00:00)
9/5
-
Supplemental Prospectus (Form 424B3)
8/19
-
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)
8/12
-
Amendment to Annual Report (Form 10-K/A)
7/28
-
7/15
-
Material Agreement, Proxy Results (Form 8-K)
6/12
-
Revised Proxy Soliciting Materials (Form DEFR14A)
5/16
-
Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q)
5/14
-
Preliminary Revised Proxy Statement (Form PRER14A)
5/6
-
Proxy Statement (Form DEF 14A)
5/1